VALISONE 0.1 %
BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 % · DIN 00027944 · BAUSCH HEALTH, CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is VALISONE?
VALISONE 0.1 % contains BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 00027944, held by BAUSCH HEALTH, CANADA INC., supplied as LOTION for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 06-May-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00027944 |
|---|---|
| Brand name | VALISONE |
| Generic / active ingredient | BETAMETHASONE (BETAMETHASONE VALERATE) : 0.1 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 0.1 % |
| Dosage form | LOTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AC01 BETAMETHASONE |
| AHFS class | 84:06.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 06-May-2021 |
| Original market date | 1980-11-04 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D07AC01 BETAMETHASONE. 20 of 73 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BETADERM CRM 0.05% | 0.05 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716618 |
| BETADERM CRM 0.1% | 0.1 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716626 |
| BETADERM LOTION 0.1% | 0.1 % | LOTION | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716634 |
| BETADERM ONT 0.05% | 0.05 % | OINTMENT | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716642 |
| BETADERM ONT 0.1% | 0.1 % | OINTMENT | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716650 |
| DIPROLENE | 0.05 % | OINTMENT | ORGANON CANADA INC. | MARKETED | DIN 00629367 |
| DIPROSONE | 0.05 % | LOTION | ORGANON CANADA INC. | MARKETED | DIN 00417246 |
| DIPROSONE | 0.05 % | CREAM | ORGANON CANADA INC. | MARKETED | DIN 00323071 |
| DIPROSONE | 0.05 % | OINTMENT | ORGANON CANADA INC. | MARKETED | DIN 00344923 |
| TARO-SONE | 0.05 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 01925350 |
Who else supplies BETAMETHASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BETAMETHASONE appears in 2437 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.